All are pretty much the same in terms of effectiveness. All work by competitive inhibition of angiotensin-converting enzymes. Captopril (Capoten) and enalapril (Vasotec) are off-patent, which makes them more economical. ACE inhibitors are great for renal protection outside and beyond their BP lowering properties.